Candel Therapeutics, Inc.

CADL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001841387

SEC filings (opens in a new tab)

In the last 90 days, Candel Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 137 institutions reported holding it in 13F filings for Q2 2026, worth $518.9M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Candel Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of CADL: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	52	1	71	+20
Shares	6.69M	1.94M	18.0M	+13.2M (+277.3%)
Value	$46.4M	$13.4M	$155.7M	+$122.8M (+372.3%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Candel Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CADL in Q4 2024
Institution	Shares	Value	% of portfolio
Baker Bros. Advisors LP	2,981,983	$25.9M	0.28%
Acorn Capital Advisors, LLC	1,939,644	$16.8M	9.06%
Braidwell LP	1,600,000	$13.9M	0.41%
Portolan Capital Management, LLC	753,745	$6.54M	0.44%
Birchview Capital, LP	60,000	$520.8K	0.42%
Maven Securities LTD	51,731	$449.0K	0.07%
Commonwealth Equity Services, LLC	41,098	$357.0K	0.00%
Oppenheimer & Co Inc	37,915	$329.1K	0.00%
Heights Capital Management, Inc	30,000	$260.4K	0.13%
Kovitz Investment Group Partners, LLC	20,000	$173.6K	0.00%
Diadema Partners LP	20,000	$173.6K	0.20%
Oxford Asset Management LLP	12,003	$104.2K	0.05%
Transform Wealth, LLC	11,577	$100.5K	0.01%
LPL Financial LLC	10,703	$92.9K	0.00%
Police & Firemen's Retirement System of New Jersey	5,419	$47.0K	0.00%
Persistent Asset Partners Ltd	6,046	$42.7K	0.04%
BNP Paribas Arbitrage, SA	3,434	$29.8K	0.00%
Advisor Group Holdings, Inc.	3,027	$26.3K	0.00%
Ikarian Capital, LLC	1,400	$12.2K	0.00%
Federation des caisses Desjardins du Quebec	1,000	$8.68K	0.00%
Caitong International Asset Management Co., Ltd	331	$2.87K	0.00%
SBI Securities Co., Ltd.	10	$87	0.00%

Sold out (2)

Institutions that held Candel Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CADL in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Atom Investors LP	14,873	$103.1K
National Bank of Canada	3	$21

Not filed for Q4 2024 yet (1)

Institutions that held Candel Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CADL in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Northpond Ventures, LLC	1,935,215	$13.4M